Concepedia

Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

Melanie J. Davies, Louise Færch, Ole Kleist Jeppesen, Arash Pakseresht, Sue D. Pedersen, Leigh Perreault, Julio Rosenstock, Iichiro Shimomura, Adie Viljoen, Thomas A. Wadden,

The Lancet · 2021 · 1.3K citations · 29 references

DOIFull text

Open access

Concepts

References

29

Statistical Analysis With Missing Data

Maureen Lahiff, Roderick J. A. Little, Donald B. Rubin · Journal of the American Statistical Association · 1989 · 17.5K citations

, , +12

Once-Weekly Semaglutide in Adults with Overweight or Obesity

John Wilding, Rachel L. Batterham, Salvatore Calanna et al. · New England Journal of Medicine · 2021 · 4.5K citations · Full text

, , +11

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J. Davies, David A. D’Alessio, Judith Fradkin et al. · Diabetes Care · 2018 · 3.5K citations · Full text

, , +17

Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death

Sreenivasa Rao Kondapally Seshasai, Stephen Kaptoge, Alexander Thompson et al. · New England Journal of Medicine · 2011 · 2.7K citations · Full text

, , +16

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

F. Xavier Pi‐Sunyer, Arne Astrup, Ken Fujioka et al. · New England Journal of Medicine · 2015 · 2.6K citations · Full text

, , +17